Ifosfamide
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Oncology & Critical Care treatment.
🧴 Clinical Application
Administer by slow intravenous infusion over at least 30 to 60 minutes (or continuous 24-hour infusion). MANDATORY: Mesna (at least 60% of the ifosfamide dose in divided increments) and aggressive IV hydration MUST ALWAYS be co-administered with every dose of ifosfamide to prevent lethal hemorrhagic cystitis.
⚠️ Side Effects
Common: Alopecia, myelosuppression, nausea, vomiting, hematuria. Rare/Severe: Severe hemorrhagic cystitis, central nervous system neurotoxicity / encephalopathy (confusion, hallucinations, cerebellar ataxia, coma due to chloroacetaldehyde), and Fanconi syndrome (nephrotoxicity).
🛡️ Safety Warnings
Black Box Warning: Hemorrhagic cystitis; Mesna uroprotection is MANDATORY. Black Box Warning: Neurotoxicity/encephalopathy (chloroacetaldehyde crossed into CNS); methylene blue (50 mg IV) is used as an antidote. Black Box Warning: Severe myelosuppression.
Jan Aushadhi Products containing Ifosfamide
Found 1 generic formulation(s) containing this active ingredient.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Ifosfamide.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Ifosfamide Injection 1gm | VIAL | ₹159.38 | Fosfa, Ifoneon | ₹383.85 | 58% Save |
Frequently Asked Questions (FAQ)
Get answers to common queries about Ifosfamide generics.